New York State Common Retirement Fund Atreca, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 04, 2022	SELL	$1.56 - $3.25 $19,656 - $40,950	-12,600 Reduced 98.31%	217 $0
Q4 2021 Feb 02, 2022	SELL	$2.87 - $6.29 $111 - $245	-39 Reduced 0.3%	12,817 $39,000
Q3 2021 Nov 02, 2021	BUY	$4.91 - $9.07 $63 - $117	13 Added 0.1%	12,856 $80,000
Q2 2021 Aug 02, 2021	SELL	$7.82 - $13.8 $88,029 - $155,346	-11,257 Reduced 46.71%	12,843 $109,000
Q4 2020 Feb 08, 2021	BUY	$13.03 - $17.09 $49,514 - $64,942	3,800 Added 18.72%	24,100 $389,000
Q2 2020 Aug 07, 2020	BUY	$12.52 - $23.45 $146,484 - $274,365	11,700 Added 136.05%	20,300 $432,000
Q3 2019 Nov 07, 2019	BUY	$10.42 - $22.04 $89,612 - $189,544	8,600 New	8,600 $105,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.